Robert G Boyle

Bob is a medicinal chemist by background with over twenty-eight years’ industrial experience. He has held positions at Pfizer, Cambridge Discovery Chemistry, Millennium Pharmaceuticals, Astex Therapeutics & Sentinel Oncology.

Bob has served as Sentinel Oncology’s Chief Executive Officer and Chair since its inception in 2005, has successfully raised multiple rounds of funding and secured multiple licensing deals with Biotech and Pharma. Sentinel Oncology has been the recipient of numerous awards & grants for innovation and Bob is a named inventor on over 60 patents & publications describing the discovery and use of small molecules for the treatment of unmet medical needs.